Chinese biopharma firm Atom Bioscience snaps over $82m in Series D round

Chinese biopharma firm Atom Bioscience snaps over $82m in Series D round

Image from Unsplash.

Stephanie Li

16 October, 2023

Edited by: Joymitra Rai

Atom BioscienceKaitai Capital

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.